CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors

被引：0
|
作者：
Yogesh T. Patel
Abigail Davis
Suzanne J. Baker
Olivia Campagne
Clinton F. Stewart
机构：
[1] St. Jude Children’s Research Hospital,Department of Pharmaceutical Sciences
[2] Cognigen Corporation,Department of Developmental Neurobiology
[3] St. Jude Children’s Research Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 84卷
关键词：
Microdialysis; CDK4/6; Pharmacokinetics; Ribociclib; Pediatrics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：447 / 452
页数：5
相关论文
共 50 条
  • [1] CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors
    Patel, Yogesh T.
    Davis, Abigail
    Baker, Suzanne J.
    Campagne, Olivia
    Stewart, Clinton F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (02) : 447 - 452
  • [2] CNS PENETRATION OF THE CDK4/6 INHIBITOR RIBOCICLIB (LEE011) IN NON-TUMOR BEARING MICE AND MICE BEARING ORTHOTOPIC PEDIATRIC BRAIN TUMORS
    Patel, Yogesh
    Davis, Abigail
    Kala, Ashish
    Roberts, Jessica
    Jacus, Megan
    Baker, Suzanne
    Roussel, Martine
    Stewart, Clinton
    NEURO-ONCOLOGY, 2016, 18 : 152 - 152
  • [3] CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice
    Campagne, Olivia
    Davis, Abigail
    Zhong, Bo
    Nair, Sreenath
    Haberman, Victoria
    Patel, Yogesh T.
    Janke, Laura
    Roussel, Martine F.
    Stewart, Clinton F.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2019, 22 : 612 - 629
  • [4] CNS penetration of cyclophosphamide and metabolites in mice bearing Group 3 medulloblastoma and non-tumor bearing mice
    Campagne, Olivia
    Davis, Abigail
    Zhong, Bo
    Roussel, Martine F.
    Stewart, Clinton F.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S91 - S92
  • [5] Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma
    Todd W. Miller
    Nicole A. Traphagen
    Jing Li
    Lionel D. Lewis
    Beatriz Lopes
    Ashok Asthagiri
    Johanna Loomba
    Jenny De Jong
    David Schiff
    Sohil H. Patel
    Benjamin W. Purow
    Camilo E. Fadul
    Journal of Neuro-Oncology, 2019, 144 : 563 - 572
  • [6] Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma
    Miller, Todd W.
    Traphagen, Nicole A.
    Li, Jing
    Lewis, Lionel D.
    Lopes, Beatriz
    Asthagiri, Ashok
    Loomba, Johanna
    De Jong, Jenny
    Schiff, David
    Patel, Sohil H.
    Purow, Benjamin W.
    Fadul, Camilo E.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 144 (03) : 563 - 572
  • [7] THE CDK4/6 INHIBITOR ABEMACICLIB IN PATIENTS WITH RECURRENT MENINGIOMA AND OTHER PRIMARY CNS TUMORS
    Coffee, Elizabeth
    Panageas, Katherine
    Young, Robert
    Morrison, Tara
    Daher, Ahmad
    Grommes, Christian
    Gavrilovic, Igor T.
    Lin, Andrew
    Miller, Alexandra
    Schaff, Lauren
    Daras, Mariza
    DeAngelis, Lisa
    Diamond, Eli
    Piotrowski, Anna
    Malani, Rachna
    Nolan, Craig
    Pentsova, Elena
    Santomasso, Bianca
    Stone, Jacqueline
    Nair, Suresh
    Mellinghoff, Ingo K.
    Kaley, Thomas
    NEURO-ONCOLOGY, 2021, 23 : 72 - 73
  • [8] A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors
    Aurora Norman
    Mahesh Seetharam
    Jacob Allred
    Jianping Kong
    Mateusz Opyrchal
    Wen Wee Ma
    Yanyan Lou
    Grace K. Dy
    Amit Mahipal
    S. John Weroha
    Andrea E. Wahner Hendrickson
    Joel M. Reid
    Alex A. Adjei
    BJC Reports, 3 (1):
  • [9] A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
    Geoerger, Birgit
    Bourdeaut, Franck
    DuBois, Steven G.
    Fischer, Matthias
    Geller, James I.
    Gottardo, Nicholas G.
    Marabelle, Aurelien
    Pearson, Andrew D. J.
    Modak, Shakeel
    Cash, Thomas
    Robinson, Giles W.
    Motta, Marlyane
    Matano, Alessandro
    Bhansali, Suraj G.
    Dobson, Jason R.
    Parasuraman, Sudha
    Chi, Susan N.
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2433 - 2441
  • [10] KINETICS OF INTERACTION OF HETEROLOGOUS ANTI-TUMOR SERUM AND HETEROLOGOUS COMPLEMENT IN NON-TUMOR BEARING MICE
    DRAKE, WP
    ROBERTS, GC
    PENDERGRAST, WJ
    MARDINEY, MR
    BIOMEDICINE, 1975, 22 (06): : 502 - 508
12345